BMS-250749

CAT: 0804-HY-120638Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-120638Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BMS-250749 is a topoisomerase I (Top I) inhibitor of the fluoroglycosyl-3,9-difluoroindolecarbazole class. BMS-250749 exhibits potent cytotoxicity and selectivity, and shows curative antitumor activity against Lewis lung cancer. BMS-250749 exhibits broad-spectrum antitumor activity superior to CPT-11 in certain preclinical xenograft models.[1].
CAS Number
[406913-72-2]
UNSPSC
12352005
Target
Topoisomerase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bms-250749.html
Smiles
O=C1NC(C2=C1C3=C(NC4=C3C=C(C=C4)F)C5=C2C6=C(C=CC(F)=C6)N5[C@H]7[C@H](O)[C@@H](O)[C@@H]([C@H](O7)CO)F)=O
Molecular Formula
C26H18F3N3O6
Molecular Weight
525.43
References & Citations
[1]Discovery of a Fluoroindolo[2,3-a]carbazole Clinical Candidate with Broad Spectrum Antitumor Activity in Preclinical Tumor Models Superior to the Marketed Oncology Drug, CPT-11
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-117074BMS-247243
HY-120623-01BMS-284640
HY-139562BMS-986318
HY-108432BMS-741672
HY-P2021BMS 180742
HY-19667BMS-561392
HY-120625BMS-358233
HY-15352-01BMS 561390
HY-115874BMS-753426
HY-145373BMS-986143

Alternative Products

CatalogName
MBS5776572BMS-250749
MBS386661-01BMS-806 (BMS 378806)
A11201-1BMS-806 (BMS 378806) 1mg
A11201-2BMS-806 (BMS 378806) 2mg
A11201-500BMS-806 (BMS 378806) 500mg
A11201-25BMS-806 (BMS 378806) 25mg
GW9859-1mgBMS-309403
GW5318-25mgBMS-3
3410/10BMS 961
4970/10BMS 688521

Popular Products